-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ExC1bpQR/8gw7ESFmJyZN6qMisHS5dDUa3+7K3xwuOcBQQsywFDyD7mc3HxX9VFP W5cJNvWaWbDgVK6rLEPM6g== 0001045463-99-000004.txt : 19990624 0001045463-99-000004.hdr.sgml : 19990624 ACCESSION NUMBER: 0001045463-99-000004 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990527 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: SEC FILE NUMBER: 005-39368 FILM NUMBER: 99635696 BUSINESS ADDRESS: STREET 1: 7 POWDER HORN DR CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 9082711001 MAIL ADDRESS: STREET 1: 7 POWDER HORN DRIVE STREET 2: P O BOX 4914 CITY: WARREN STATE: NJ ZIP: 07059 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SCULLY WILLIAM P CENTRAL INDEX KEY: 0001045463 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: P O BOX 357 STREET 2: ONE MAIN ST CITY: CHATHAM STATE: NJ ZIP: 07928 MAIL ADDRESS: STREET 1: C/O MCGRATH DOYLE & PHAIR STREET 2: 150 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10038 SC 13D 1 AMENDED United States Securities and Exchange Commission Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 CELGENE CORP. (Name Of Issuer) Common (Title of Class of Securities) 151020104 (CUSIP Number) William P. Scully c/o McGrath, Doyle & Phair 150, Broadway, Suite 1703 New York, NY 10038 Telephone: (212) 571-2300 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) 5/11/99 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement of Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13-1d(b)(3) or (4), check the following box [ ]. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes.) SCHEDULE 13D page 2 of 4 pages 1. NAME OF REPORTING PERSON William P. Scully SS OR IRS IDENTIFICATION NO. OF THE ABOVE PERSON 2. CHECK THE APPROPRIATE BOX IF A Controls voting and dispositive (a)[x] MEMBER OF A GROUP power for himself and his family.(b)[ ] 3. SEC USE ONLY 4. SOURCE OF FUNDS PF 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS [ ] (IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) 6. CITIZENSHIP OR PLACE OF ORGANIZATION USA NUMBER OF 7. SOLE VOTING POWER 725,900 SHARES BENEFICIALLY 8. SHARED VOTING POWER OWNED BY EACH 9. SOLE DISPOSITIVE POWER 725,900 REPORTING PERSON WITH 10. SHARED DISPOSITIVE POWER 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH 725,900 REPORTING PERSON 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) [ ] EXCLUDES CERTAIN SHARES 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 4.3337% 14. TYPE OF REPORTING PERSON IN SCHEDULE 13D page 3 of 4 pages Item 1. Security and Issuer. a) Name and Address of Principal Executive Officers of Issuer: Celgene Corp. 7 Powderhorn Drive Warren, NJ 07059 (b) Title and class of Common Stock Equity Securities: Item 2. Identity and Background. (a) Name of Person Filing William P. Scully (b) State of Incorporation: N/A (c) Principal of Business: Investor (d) Address of Principal Business and Principal Office: c/o McGrath, Doyle & Phair 150 Broadway, # 1703 New York, NY 10038 (e) Criminal Proceedings: N/A (f) Civil Proceedings: N/A SCHEDULE 13D page 4 of 4 pages Item 3. Source and Amount of Funds or other Consideration. Personal Funds - $1,074,932 paid for additional purchases Item 4. Purpose of Transaction. Material acquisition for investment purposes Item 5. Interests in Securities of the Issuer. (a) Number of Shares 725,900 shares Beneficially Owned: Percent of Class: 4.3337% (b) Sole Power to Vote, Direct the Vote of, or 725,900 shares Dispose of Shares: Shared Power to Vote, Direct the Vote of, or None Dispose of Shares: (c) Recent Transactions: Investor acquired approximately an additional 0.676% of the common shares outstanding since the last filing of Schedule 13D. However, please note that the company issued additional shares since the last Schedule 13D filing which diluted the investors holdings. Investor previously filed a combined report with Donald P. Moriarty. Mr. Moriarty is filing a separate Schedule 13D. (d) Rights to Dividends or Sales Proceeds: N/A (e) Date of Cessation of Five Percent Beneficial Ownership: N/A Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. N/A Item 7. Material to be Filed as Exhibits. N/A Nicholas Jacangelo, CPA -----END PRIVACY-ENHANCED MESSAGE-----